Margaret L. Salisbury, M.D.

Assistant Professor

Faculty Appointments
Assistant Professor of Medicine
M.S., Clinical Research Design and Statistical Analysis, University of Michigan, Ann Arbor, MichiganM.D., University of Missouri, Columbia, MissouriB.S., Biology, University of Missouri, Columbia, Missouri
Clinical Description
Interstitial Lung Disease
Hypersensitivity Pneumonitis
O'Dwyer DN, Ashley SL, Gurczynski SJ, Xia M, Wilke C, Falkowski NR, Norman KC, Arnold KB, Huffnagle GB, Salisbury ML, Han MK, Flaherty KR, White ES, Martinez FJ, Erb-Downward JR, Murray S, Moore BB, Dickson RP. Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis. Am. J. Respir. Crit. Care Med. 2019 May 5/1/2019; 199(9): 1127-38. PMID: 30789747, DOI: 10.1164/rccm.201809-1650OC, ISSN: 1535-4970.

Salisbury ML, Gu T, Murray S, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, Flaherty KR. Hypersensitivity Pneumonitis: Radiologic Phenotypes Are Associated With Distinct Survival Time and Pulmonary Function Trajectory. Chest [print-electronic]. 2019 Apr; 155(4): 699-711. PMID: 30243979, PII: S0012-3692(18)32438-3, DOI: 10.1016/j.chest.2018.08.1076, ISSN: 1931-3543.

Sheth JS, Xia M, Murray S, Martinez CH, Meldrum CA, Belloli EA, Salisbury ML, White ES, Holtze CH, Flaherty KR. Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis. Respir Med [print-electronic]. 2019 Mar; 148: 6-12. PMID: 30827476, PII: S0954-6111(19)30017-4, DOI: 10.1016/j.rmed.2019.01.008, ISSN: 1532-3064.

Wu X, Kim GH, Salisbury ML, Barber D, Bartholmai BJ, Brown KK, Conoscenti CS, De Backer J, Flaherty KR, Gruden JF, Hoffman EA, Humphries SM, Jacob J, Maher TM, Raghu G, Richeldi L, Ross BD, Schlenker-Herceg R, Sverzellati N, Wells AU, Martinez FJ, Lynch DA, Goldin J, Walsh SLF. Computed Tomographic Biomarkers in Idiopathic Pulmonary Fibrosis. The Future of Quantitative Analysis. Am. J. Respir. Crit. Care Med. 2019 Jan 1/1/2019; 199(1): 12-21. PMID: 29986154, DOI: 10.1164/rccm.201803-0444PP, ISSN: 1535-4970.

Salisbury ML, Gross BH, Chughtai A, Sayyouh M, Kazerooni EA, Bartholmai BJ, Xia M, Murray S, Myers JL, Lagstein A, Konopka KE, Belloli EA, Sheth JS, White ES, Holtze C, Martinez FJ, Flaherty KR. Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis. Eur. Respir. J [electronic-print]. 2018 Aug; 52(2): PMID: 29946001, PMCID: PMC6181129, PII: 13993003.00443-2018, DOI: 10.1183/13993003.00443-2018, ISSN: 1399-3003.

Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Reply to Fernández Pérez: Diagnostic Decision-Making in Hypersensitivity Pneumonitis: Toward a Consensus Statement. Am. J. Respir. Crit. Care Med. 2018 Jun 6/15/2018; 197(12): 1647-8. PMID: 29505269, PMCID: PMC6006408, DOI: 10.1164/rccm.201801-0125LE, ISSN: 1535-4970.

Salisbury ML, Lynch DA. Toward Early Identification of Clinically Relevant Interstitial Lung Disease. Am. J. Respir. Crit. Care Med. 2017 Dec 12/1/2017; 196(11): 1368-9. PMID: 28731358, PMCID: PMC5803668, DOI: 10.1164/rccm.201706-1235ED, ISSN: 1535-4970.

Salisbury ML, Tolle LB, Xia M, Murray S, Tayob N, Nambiar AM, Schmidt SL, Lagstein A, Myers JL, Gross BH, Kazerooni EA, Sundaram B, Chughtai AR, Martinez FJ, Flaherty KR. Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients. Respir Med [print-electronic]. 2017 Oct; 131: 229-35. PMID: 28947036, PMCID: PMC5679475, PII: S0954-6111(17)30309-8, DOI: 10.1016/j.rmed.2017.08.025, ISSN: 1532-3064.

Salisbury ML, Myers JL, Belloli EA, Kazerooni EA, Martinez FJ, Flaherty KR. Diagnosis and Treatment of Fibrotic Hypersensitivity Pneumonia. Where We Stand and Where We Need to Go. Am. J. Respir. Crit. Care Med. 2017 Sep 9/15/2017; 196(6): 690-9. PMID: 28002680, PMCID: PMC5620675, DOI: 10.1164/rccm.201608-1675PP, ISSN: 1535-4970.

Salisbury ML, Han MK, Dickson RP, Molyneaux PL. Microbiome in interstitial lung disease: from pathogenesis to treatment target. Curr Opin Pulm Med. 2017 Sep; 23(5): 404-10. PMID: 28650861, PMCID: PMC5638128, DOI: 10.1097/MCP.0000000000000399, ISSN: 1531-6971.

Salisbury ML, Lynch DA, van Beek EJ, Kazerooni EA, Guo J, Xia M, Murray S, Anstrom KJ, Yow E, Martinez FJ, Hoffman EA, Flaherty KR, . Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes. Am. J. Respir. Crit. Care Med. 2017 Apr 4/1/2017; 195(7): 921-9. PMID: 27767347, PMCID: PMC5387708, DOI: 10.1164/rccm.201607-1385OC, ISSN: 1535-4970.

Salisbury ML, Xia M, Murray S, Bartholmai BJ, Kazerooni EA, Meldrum CA, Martinez FJ, Flaherty KR. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling. Respir Med [print-electronic]. 2016 Sep; 118: 88-95. PMID: 27578476, PMCID: PMC5008035, PII: S0954-6111(16)30170-6, DOI: 10.1016/j.rmed.2016.07.016, ISSN: 1532-3064.

Salisbury ML, Xia M, Zhou Y, Murray S, Tayob N, Brown KK, Wells AU, Schmidt SL, Martinez FJ, Flaherty KR. Idiopathic Pulmonary Fibrosis: Gender-Age-Physiology Index Stage for Predicting Future Lung Function Decline. Chest [print-electronic]. 2016 Feb; 149(2): 491-8. PMID: 26425858, PMCID: PMC4944785, PII: S0012-3692(15)00032-X, DOI: 10.1378/chest.15-0530, ISSN: 1931-3543.